María Martínez
Director of Finance/CFO at Progenika Biopharma SA
Profile
María Martínez is currently working as a Finance Director at Progenika Biopharma SA. Previously, she held the same position at BRAINco Biopharma SL.
Ms. Martínez completed her undergraduate degree at the University of Deusto.
María Martínez active positions
Companies | Position | Start |
---|---|---|
Progenika Biopharma SA
Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Director of Finance/CFO | - |
Former positions of María Martínez
Companies | Position | End |
---|---|---|
BRAINco Biopharma SL
BRAINco Biopharma SL Medical SpecialtiesHealth Technology BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain. | Director of Finance/CFO | - |
Training of María Martínez
University of Deusto | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Progenika Biopharma SA
Progenika Biopharma SA Medical SpecialtiesHealth Technology Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain. | Health Technology |
BRAINco Biopharma SL
BRAINco Biopharma SL Medical SpecialtiesHealth Technology BRAINco Biopharma SL develops and produces diagnosis and treatment for neurological and psychiatric diseases. It develops drugs directed against therapeutic targets and diagnostic biochips, prognosis, and prediction of individual response to drug treatment. The company was founded by Laureano Simon Buela in 2008 and is headquartered in Bilbao, Spain. | Health Technology |
- Stock Market
- Insiders
- María Martínez